Product Details
BBI Solutions offers a next generation FAD-dependent GlucoseDehydrogenase (FAD-GDH). FAD-GDH with reduced xylose interference is part of our market leading range of enzymes for blood glucose monitoring, it reduces cross reactivity with a range of sugars, provides increased specificity to glucose and improves reactivity and stability. Our two grades of FAD-GDH (GLD1 and GLD3), offer proven performance in a range of systems, the decision on which one’s right for you will depend on your individual platform.